rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
13
|
pubmed:dateCreated |
1997-5-20
|
pubmed:abstractText |
We investigated the value of the proliferating cell nuclear antigen labeling index ratio (PCNA-LI ratio: PCNA-LI of cancer/PCNA-LI of surrounding non-cancerous liver tissue) to clarify the prognosis of the patients bearing small hepatocellular carcinomas (HCC) less than 20 mm in diameter and treated by percutaneous ethanol injection therapy (PEIT).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0172-6390
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
44
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
245-50
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9058153-Aged,
pubmed-meshheading:9058153-Biopsy,
pubmed-meshheading:9058153-Carcinoma, Hepatocellular,
pubmed-meshheading:9058153-Cell Division,
pubmed-meshheading:9058153-Ethanol,
pubmed-meshheading:9058153-Female,
pubmed-meshheading:9058153-Humans,
pubmed-meshheading:9058153-Injections, Intralesional,
pubmed-meshheading:9058153-Liver Neoplasms,
pubmed-meshheading:9058153-Male,
pubmed-meshheading:9058153-Middle Aged,
pubmed-meshheading:9058153-Neoplasm Recurrence, Local,
pubmed-meshheading:9058153-Prognosis,
pubmed-meshheading:9058153-Proliferating Cell Nuclear Antigen,
pubmed-meshheading:9058153-Retrospective Studies
|
pubmed:articleTitle |
Proliferating cell nuclear antigen and grade of malignancy in small hepatocellular carcinoma--evaluation in US-guided specimens.
|
pubmed:affiliation |
First Department of Internal Medicine, Okayama University Medical School, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|